Disopyramide

DEA Class; Rx

Common Brand Names; Norpace, Norpace CR

  • Antidysrhythmics, Ia

Oral class IA antiarrhythmic; similar pharmacology to procainamide and quinidine
Used only for life-threatening ventricular arrhythmia
Significant proarrhythmic, anticholinergic, and negative inotropic properties limit its use

Indicated for the treatment of documented, life-threatening arrhythmias such as sustained ventricular tachycardia.
For maintenance of sinus rhythm in patients with atrial fibrillation or atrial flutter.

Hypersensitivity

Cardiogenic shock, preexisting second or third degree heart block, congenital QT syndrome, sick sinus syndrome

  • Xerostomia (32%)
  • Urinary hesitancy (23%)
  • Constipation (11%)
  • Impotence
  • Urinary urgency
  • Urinary retention
  • Dry throat
  • Weight gain
  • Abdominal distension
  • Flatulence
  • Anorexia
  • Vomiting
  • Nausea
  • Dermatoses
  • Pruritus
  • Generalized rash
  • Increased triglycerides and cholesterol
  • Hypokalemia
  • Muscle weakness
  • Muscular pain
  • Dyspnea
  • Blurred vision
  • Dry eyes
  • Fatigue
  • Malaise
  • Headache
  • Dizziness
  • Nervousness
  • Syncope
  • Hypotension
  • Chest pain
  • Edema

CHF, ECG abnormalities, electrolyte abnormalities (hypo/hyper K), glaucoma, hypoglycemia, myasthenia gravis, sick sinus syndrome, BPH/urinary retention, need normal potassium prior to use, hypotension, cardiac myopathies, heart failure, prostatic enlargement, Wolff-Parkinson-White syndrome, bundle branch block, hepatic/renal impairment

Hypotension may occur

May cause QTc prolongation and subsequent torsade de pointes

Can both precipitate and exacerbate HF due to marked myocardial depressant effects in HF

Pregnancy Category: C

Lactation: crosses into breast milk, discontinue drug or do not nurse

Adults

800 mg/day PO; however, up to 1600 mg/day PO has been used in the hospital setting to treat severe refractory ventricular tachycardia.

Elderly

800 mg/day PO; however, up to 1600 mg/day PO has been used in the hospital setting to treat severe refractory ventricular tachycardia.

Adolescents

15 mg/kg/day PO.

Children

5—12 years: 15 mg/kg/day PO.
1—4 years: 20 mg/kg/day PO.

Infants

30 mg/kg/day PO.

Disopyramide phosphate

capsule

  • 100mg
  • 150mg

capsule, controlled-release

  • 100mg
  • 150mg

About the Author

You may also like these

0